Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy

Thyroid - Tập 16 Số 12 - Trang 1229-1242 - 2006
Jacqueline Jonklaas1,2, Nicholas J. Sarlis3,4, Danielle R. Litofsky4, Kenneth B. Ain5, S T Bigos6, James D. Brierley7,8, David S. Cooper9, Bryan R. Haugen10, Paul W. Ladenson11, James A. Magner12, Jacob Robbins13, Douglas S. Ross14,15, Monica C. Skarulis13, Harry R. Maxon16, Steven I. Sherman17,4
1Georgetown University
2Georgetown University Medical Center, Washington, D.C.
3Present address: Sanofi-Aventis Pharmaceuticals, Bridgewater, New Jersey.
4University of Texas M.D. Anderson Cancer Center, Houston, Texas
5#N##TAB##TAB##TAB##TAB# Univ. of Kentucky#N##TAB##TAB##TAB#
6Maine Medical Center, Portland, Maine
7Department of Radiation Oncology
8Princess Margaret Hospital, Toronto, Ontario, Canada
9Sinai Hospital, Baltimore, Maryland
10University of Colorado at Denver and Health Sciences Center, Aurora, Colorado.
11Johns Hopkins University School of Medicine, Baltimore, Maryland
12Genzyme Corporation, Cambridge, Massachusetts
13National Institutes of Health, Bethesda, Maryland
14Harvard University
15Massachusetts General Hospital, Boston, Massachusetts
16University of Cincinnati Medical Center, Cincinnati, Ohio
17Endocrine Neoplasia & HD

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.3322/canjclin.55.1.10

10.1001/jama.295.18.2179

10.1002/(SICI)1097-0142(19980901)83:5<1012::AID-CNCR28>3.0.CO;2-9

10.1007/s002689900016

10.1210/jc.83.4.1121

10.1002/1097-0142(19840215)53:4<982::AID-CNCR2820530427>3.0.CO;2-E

10.1001/archsurg.133.1.89

10.1210/jc.83.12.4195

10.1007/BF00348202

10.1007/BF00294746

10.1097/00000658-199806000-00015

10.1007/s10434-004-1165-1

10.1210/jcem.86.4.7407

10.1089/thy.1997.7.265

10.1002/(SICI)1097-0142(19980115)82:2<389::AID-CNCR19>3.0.CO;2-V

10.1016/S0360-3016(01)02686-4

10.1210/jc.75.3.714

10.1002/1097-0142(197707)40:1<195::AID-CNCR2820400131>3.0.CO;2-C

10.1007/s002590000420

Lerch H, 1997, J Clin Oncol, 15, 2067, 10.1200/JCO.1997.15.5.2067

10.7326/0003-4819-129-8-199810150-00007

10.1016/S1072-7515(03)00332-6

10.1210/jc.2003-031167

10.1007/s00268-002-6612-1

10.1210/jc.84.3.829

10.1089/thy.1995.5.35

10.1016/S0140-6736(54)91480-4

10.1016/0002-9343(94)90321-2

Staunton MD, 1994, Eur J Surg Oncol, 20, 613

Young RL, 1980, J Nucl Med, 21, 733

10.1016/0360-3016(88)90381-1

10.1016/S0002-9610(05)80539-2

10.1001/archsurg.1988.01400290051008

10.1001/archsurg.133.4.419

10.1089/thy.1998.8.737

10.1210/jc.81.12.4318

10.1080/078538902321117760

10.1038/ncpendmet0020

10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B

10.7326/0003-4819-127-8_Part_2-199710151-00064

10.1089/thy.2006.16.109

10.1038/sj.bjc.6601395

10.1097/00000478-200211000-00014

Fassina AS, 1993, Tumori, 79, 314, 10.1177/030089169307900506

10.1097/01.pas.0000135519.34847.f6

10.1089/thy.1994.4.233

10.1136/jech.47.6.491

10.1097/01.smj.0000224337.77074.57

10.1023/A:1007570405888

Chamberlain J, 1991, Trial Co-ordinating Centre. Br J Cancer, 64, 1151

10.1080/09553000110042127

10.1007/s002590050499

10.1016/S0140-6736(86)92159-8

10.1210/jc.2005-2009

Hay ID, 2002, Trans Am Clin Climatol Assoc, 113, 241

Abel U, 2003, Clin Lab, 49, 367

10.1097/00043426-199205000-00005